You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 1, January 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Herpesviruses and Parkinsonism

Herpes Simplex Virus Types 1 and 2, and Cytomegalovirus Antibodies in Serum and CSF

Reijo J. Marttila, MD; Urpo K. Rinne, MD; Pekka Halonen, MD; David L. Madden, DVM, PhD; John L. Sever, MD, PhD

Arch Neurol. 1981;38(1):19-21.


Abstract

• Antibodies against herpes simplex virus (HSV) types 1 and 2 and cytomegalovirus (CMV) were assayed with a microindirect hemagglutination (IHA) test in the serum of 67 pairs of patients with Parkinson's disease and controls. Cerebrospinal fluid from 30 pairs was assayed. All patient and control serum was tested with a radioimmunoassay (RIA) for antibodies against HSV type 1 subunit antigens. Serum IHA antibody level against HSV type 1 was increased in patients with Parkinson's disease and RIA antibody levels against the same viral antigen were significantly higher in the patients than controls. Herpes simplex virus type 2 and CMV serum antibodies were equal in the patient and control groups. Most of the CSF samples tested negatively for IHA; small and comparable numbers of the patients and controls had low antibody levels against HSV and CMV antigens.



Author Affiliations

From the Departments of Neurology (Drs Marttila and Rinne) and Virology (Dr Halonen), University of Turku, Turku, Finland, and the Infectious Diseases Branch, National Institute for Neurological and Cerebral Disorders and Stroke, National Institutes of Health, Bethesda, Md (Drs Madden and Sever).


Footnotes

Accepted for publication April 13, 1980.

Reprint requests to Department of Neurology, University of Turku, SF-20520 Turku 52, Finland (Dr Marttila).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infection of the basal ganglia by a murine coronavirus
Fishman et al.
Science 1985;229:877-879.
ABSTRACT  

Human Cytomegalovirus Infection and Disorders of the Nervous System
Bale
Arch Neurol 1984;41:310-320.
ABSTRACT  

Pathogenesis of Parkinson's Disease
Mann and Yates
Arch Neurol 1982;39:545-549.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.